{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:38:39Z","timestamp":1791005919991,"version":"4.1.0"},"reference-count":54,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Technol Cancer Res Treat"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Background: Esophageal cancer is one of the most common cancers with significant morbidity and mortality. It is important to predict the prognosis of patients. The purpose of this study was to comprehensively assess the prognostic and clinicopathologic significance of NLR in patients with esophageal cancer. Methods: A systematic literature search was performed using PubMed, Cochrane Library, Embase, Web of Science, MEDLINE, and CNKI. This meta-analysis was conducted in accordance with PRISMA guidelines. Hazard ratio (HR) with 95% confidence interval (CI) was used as the effect estimation to evaluate the prognostic role of NLR. Odds ratio (OR) was used to evaluate the relation between NLR and clinicopathologic characteristics. Results: A total of 8431 patients from 32 studies were included in this meta-analysis. The pooled results showed that elevated NLR might predict poor prognosis: The factors considered included overall survival (OS) (HR, 1.57; 95% CI, 1.40-1.75; P\u2009&lt;\u2009.001), cancer-specific survival (CSS) (HR, 1.28; 95% CI, 1.09-1.49; P\u2009&lt;\u2009.001), progression-free survival (PFS) (HR, 1.45; 95% CI, 1.29-1.72; P\u2009&lt;\u2009.001), and disease-free survival (DFS) (HR,1.58; 95% CI, 1.27-1.97; P\u2009&lt;\u2009.001). High NLR was also associated with tumor differentiation, tumor length, tumor invasion depth, lymph node metastasis, and clinical stage. No significant association was observed between NLR and metastasis stage (OR, 1.69; 95% CI, 0.98-2.98; P\u2009=\u2009.058). Conclusions: The results of this meta-analysis suggest that elevated NLR value might predict poor prognosis (OS, CSS, PFS, and DFS), according to abnormal clinicopathologic parameters.<\/jats:p>","DOI":"10.1177\/15330338211070140","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T14:40:53Z","timestamp":1642084853000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis"],"prefix":"10.1177","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-2959","authenticated-orcid":false,"given":"Binfeng","family":"Li","sequence":"first","affiliation":[{"name":"Hubei Cancer Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiong","sequence":"additional","affiliation":[{"name":"Hubei Cancer Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhong","family":"Yi","sequence":"additional","affiliation":[{"name":"Hubei Cancer Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Hubei Cancer Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"bibr1-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25516"},{"key":"bibr2-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025"},{"key":"bibr3-15330338211070140","doi-asserted-by":"publisher","DOI":"10.3109\/02841869509093641"},{"key":"bibr4-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1038\/srep12493"},{"key":"bibr5-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw012"},{"key":"bibr6-15330338211070140","doi-asserted-by":"publisher","DOI":"10.7150\/jca.9569"},{"key":"bibr7-15330338211070140","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S77099"},{"key":"bibr8-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4869-5"},{"key":"bibr9-15330338211070140","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S126637"},{"key":"bibr10-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"bibr11-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"bibr12-15330338211070140","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS)for assessing the quality of nonrandomized studies in meta-analysis. 2017. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed December 14, 2017."},{"key":"bibr13-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1038\/srep42581"},{"issue":"7","key":"bibr14-15330338211070140","first-page":"1061","volume":"25","author":"Zhang JY","year":"2017","journal-title":"Modern Oncology"},{"key":"bibr15-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-017-1090-5"},{"issue":"2","key":"bibr16-15330338211070140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejso.2016.11.018","volume":"43","author":"Hirahara N","year":"2017","journal-title":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"bibr17-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12445"},{"key":"bibr18-15330338211070140","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S115011"},{"issue":"2","key":"bibr19-15330338211070140","first-page":"1764","volume":"9","author":"Zhang P","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"bibr20-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168299"},{"key":"bibr21-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2696-0"},{"key":"bibr22-15330338211070140","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11259"},{"issue":"21","key":"bibr23-15330338211070140","first-page":"1431","volume":"23","author":"Liu XM","year":"2016","journal-title":"CHIN J CANCER PREV TREAT"},{"key":"bibr24-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-015-1197-0"},{"key":"bibr25-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12322"},{"key":"bibr26-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-016-0179-5"},{"key":"bibr27-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2015.09.003"},{"issue":"13","key":"bibr28-15330338211070140","first-page":"1","volume":"13","author":"Wu Y","year":"2015","journal-title":"Chinese and Foreign Medical Research"},{"issue":"11","key":"bibr29-15330338211070140","first-page":"1258","volume":"35","author":"Su ZJ","year":"2015","journal-title":"Tumor"},{"key":"bibr30-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1038\/srep18811"},{"issue":"7","key":"bibr31-15330338211070140","first-page":"2180","volume":"5","author":"Liu JS","year":"2015","journal-title":"Am J Cancer Res"},{"issue":"10","key":"bibr32-15330338211070140","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ejso.2015.07.008","volume":"41","author":"Hirahara N","year":"2015","journal-title":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"bibr33-15330338211070140","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.6.2245"},{"key":"bibr34-15330338211070140","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i18.5591"},{"key":"bibr35-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12296"},{"issue":"9","key":"bibr36-15330338211070140","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.dld.2014.05.009","volume":"46","author":"Yoo EJ","year":"2014","journal-title":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"7","key":"bibr37-15330338211070140","volume":"12","author":"Wang J","year":"2014","journal-title":"J Transl Med"},{"issue":"58","key":"bibr38-15330338211070140","volume":"12","author":"Feng JF","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"4","key":"bibr39-15330338211070140","first-page":"294","volume":"36","author":"Chen H","year":"2014","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology"},{"key":"bibr40-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/504365"},{"key":"bibr41-15330338211070140","first-page":"1605","volume":"6","author":"Feng JF","year":"2013","journal-title":"Onco Targets Ther"},{"key":"bibr42-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1754-8"},{"key":"bibr43-15330338211070140","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2011.308"},{"key":"bibr44-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-011-1130-7"},{"key":"bibr45-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.701"},{"key":"bibr46-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3533-9"},{"key":"bibr47-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"bibr48-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205"},{"key":"bibr49-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1023\/B:AGEN.0000029415.62384.ba"},{"key":"bibr50-15330338211070140","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4708-8"},{"key":"bibr51-15330338211070140","unstructured":"Freng A, Daae LN, Engeland A, et al. Malignant epithelial tumours in the upper digestive tract: a dietary and socio-medical case-control and survival study. (0954-3007 [Print])."},{"key":"bibr52-15330338211070140","unstructured":"Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. (0008-543X [Print])."},{"key":"bibr53-15330338211070140","unstructured":"Mariette C, Maurel A, Fau - Fabre S, Fau - Balon JM, Fau - Triboulet JP, Triboulet JP. [Preoperative prognostic factors for squamous cell carcinomas of the thoracic esophagus]. (0399-8320 [Print])."},{"key":"bibr54-15330338211070140","unstructured":"Shimada H, Nabeya Y, Fau - Okazumi S-I, et al. Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. (0039-6060 [Print])."}],"container-title":["Technology in Cancer Research &amp; Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15330338211070140","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15330338211070140","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15330338211070140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:09:36Z","timestamp":1777702176000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15330338211070140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["10.1177\/15330338211070140"],"URL":"https:\/\/doi.org\/10.1177\/15330338211070140","relation":{},"ISSN":["1533-0346","1533-0338"],"issn-type":[{"value":"1533-0346","type":"print"},{"value":"1533-0338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"15330338211070140"}}